18 www.oslobusinessmemo.no
News in English
One yearfrom idea Juni • Årg 4 • 2013
Egil Myklebust, COB, Otivio AS. Photo:OBM
Venture capital to Otivio
Oslo based medtech company Otivio AS has raised NOK 5 million in venture capital from private investors. Approximately half was raised by existing shareholders, including Otivio CEO Iacob Mathiesen. Otivio develops treatment solutions and instruments based on technology, originally developed at the University of Oslo, which improves blood flow to the skin of patients. The company develops a product for temperature management of patients and one product for wound healing. Both systems rely on the improved blood flow to the skin. Chairman
At the end of last year, one of the captains of Norwegian industry, former Norsk Hydro CEO Egil Myklebust, was elected new chairman of the board of Otivio. - He is a strategist with vast experience, and we are very happy that he will spend some of his time and experience helping a company like ours, Mathiesen says. With new capital in place, Otivio has financing throughout the year, during which Mathiesen hopes to obtain a CE marked product for wound healing and obtain certification of Otivio according to ISO 13485. Another year is needed to complete clinical trials before Otivio’s product will enter the markets, according to Mathiesen.
http://oslomedtech.no
Marte Bratlie's startup company RemovAid shows that even in the development ofmedtech equipment it is p
Just over a year ago, the 30 year old doctor and Ph. D. student Marte Bratlie had an idea. Today she has a company and a patent pending prototype. Text: PER GJØRVAD Photo: GORM K. GAARE
Marte Bratlie and the company she started, RemovAid, shows that even in the development of medtech equipment it is possible to take great strides in a short time. While she worked with contraceptive related issues, she noted that the use of longacting contraceptives, like
birth control implant, has shown strong growth over the recent years. And based on her experiences, she started questioning the established procedures to remove the implants.
a physician and clinician Bratlie noted the often random process of removing the rods. - It is an unpredictable and unproductive process, which in some cases can take a long time. So I thought there must be an easier way. And that was the start of the idea, says Marte Bratlie today. The idea was to develop a device which will simplify the process of removing the contraception rods. Currently, there are no such devices in the market.
Simplified
Partnership
The procedure to insert the implant was simplified in 2011 when a new introducer was launched in the market, but as
The prototype is developed together with RemovAid`s product development partner TTP. The contact with TTP was